The secretion of insulin-like growth-factor-binding proteins (IGFBPs) and expression of the genes encoding IGFBP-I, IGFBP-2 and IGFBP-3 have been studied in a panel of cell lines derived from breast carcinomas, Wilms' tumour, neuroblastoma, retinoblastoma, colon carcinoma, liver adenocarcinoma, Burk
Cytokines and growth factors modulate cell growth and insulin-like growth factor binding protein secretion by the human salivary cell line (HSG)
โ Scribed by Joseph Katz; Hana Weiss; Boleslaw Goldman; Hana Kanety; Bethel Stannard; Derek Leroith; Joshua Shemer
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 677 KB
- Volume
- 165
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We observed that all-trans-retinoic acid (RA) down-regulated insulin-like growth factor binding proteins (IGFBPs) in cultured human hepatoma cells (Hep 3B, PLC/PRF/5, and Hep G2); therefore, we characterized the role of this down-regulation in cell growth. Treatment with 10 micromol/L RA revealed a
differentiation is linked to growth of Caco-2 cells, with markers of functional differentiation increasing only after the cells stop proliferating (Pinto e t al., 1983). Given these limitations, Caco-2 cells appear to represent the most relevant in vitro model currently available for study of prolif
The modulation of insulin-like growth factor-binding protein (IGFBP) secretion is an important variable affecting muscle cell metabolism, proliferation, and differentiation. We have previously shown that secretion of IGFBP-4 and IGFBP-5 by L6 and BC 3 H-1 muscle cells was stimulated by treatment wit
Several cell types have been shown to secrete insulin-like growth factor binding proteins (IGF-BP) in vitro. Since IGF-BP influences cell responsiveness to IGF, three muscle cell types were investigated to determine if they produced IGF-BP and to identify factors that regulate IGF-BP secretion. Porc